Advertisement

Managing an Inadequate Response to the First Agent

Changing Doses or Drugs, Adding Drugs
  • L. Michael Prisant
Chapter
Part of the Current Clinical Practice book series (CCP)

Abstract

Less than 50% of patients respond to the initial choice of antihypertensive therapy. Some consideration should be given as to why the blood pressure did not achieve the intended goal to the selected medication. There are several approaches to managing an inadequate response to the first agent. These include changing the dose or the drug and adding drugs.

Keywords

Calcium Antagonist Antihypertensive Therapy Angiotensin Receptor Blocker Sodium Intake Inadequate Response 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (1997) Arch Intern Med 157 (21): 2413–2446.Google Scholar
  2. 2.
    Gifford RW, Tarazi RC (1978) Resistant hypertension: diagnosis and management. Ann Intern Med 88: 661–665.PubMedGoogle Scholar
  3. 3.
    Setaro JF, Black HR (1992) Refractory hypertension. N Engl J Med 327: 543–547.PubMedCrossRefGoogle Scholar
  4. 4.
    Fagan TC (1994) Remembering the lessons of basic pharmacology. Arch Intern Med 154 (13): 1430, 1431.CrossRefGoogle Scholar
  5. 5.
    Brunner HR, Ménard J, Waeber B, et al. (1990) Treating the individual patient: considerations on dose, sequential monotherapy and drug combinations. J Hyper-tens 8: 3–11.CrossRefGoogle Scholar
  6. 6.
    Prisant LM, Weir MR, Papademetriou V, et al. (1995) Low-dose drug combination therapy: an alternative first-line approach to hypertension treatment. Am Heart J 130 (2): 359–366.PubMedCrossRefGoogle Scholar
  7. 7.
    Moser M, Prisant LM (1997) Low-dose combination therapy in hypertension. Am Fam Phys 56 (5): 1275–1282.Google Scholar
  8. 8.
    Sutton JM, Bagby SP (1992) Nontraditional combination pharmacotherapy of hypertension. Cleve Clin J Med 59: 459–468.PubMedGoogle Scholar
  9. 9.
    Burris JF, Weir MR, Oparil S, Weber M, Cady WJ, Stewart WH (1990) An assessment of diltiazem and hydrochlorothiazide in hypertension: application of factorial trial design to a multicenter clinical trial of combination therapy. JAMA 263 (11): 1507–1512.PubMedCrossRefGoogle Scholar
  10. 10.
    Prisant LM, Can AA, Nelson EB, Winer N, Velasquez MT, Gonasun LM (1989) Isradipine vs propranolol in hydrochlorothiazide-treated hypertensives: a multicenter evaluation. Arch Intern Med 149 (11): 2453–2457.PubMedCrossRefGoogle Scholar
  11. 11.
    Prisant LM, Doll NC (1997) Hypertension: the rediscovery of combination therapy. Geriatrics 52: 28–38.PubMedGoogle Scholar
  12. 12.
    Oster JR, Epstein M (1987) Fixed-dose combination medications for the treatment of hypertension: a critical review. J Clin Hypertens 3 (3): 278–293.PubMedGoogle Scholar
  13. 13.
    Neutel JM (1996) Metabolic manifestations of low-dose diuretics. Am J Med 101(3A):71 S-82S.Google Scholar
  14. 14.
    Prisant LM, Neutel JM, Papademetriou V, DeQuattro V, Hall WD, Weir MR (1998) Low-dose combination treatment for hypertension versus single-drug treatment—bisoprolol/hydrochlorothiazide versus amlodipine, enalapril, and placebo: combined analysis of comparative studies. Am J Ther 5: 313–321.PubMedCrossRefGoogle Scholar
  15. 15.
    Applegate WB, Cohen JD, Wolfson P, Davis A, Green S (1996) Evaluation of blood pressure response to the combination of enalapril (single dose) and diltiazem ER (four different doses) in systemic hypertension. Am J Cardiol 78 (1): 51–55.PubMedCrossRefGoogle Scholar
  16. 16.
    DeQuattro V, Lee D, Messerli F (1997) Efficacy of combination therapy with trandolapril and verapamil SR in primary hypertension: a 4 x 4 trial design. The Trandolapril Study Group. Clin Exp Hypertens 19 (3): 373–387.PubMedCrossRefGoogle Scholar
  17. 17.
    Frishman WH, Ram CV, McMahon FG, et al. (1995) Comparison of amlodipine and benazepril monotherapy to amlodipine plus benazepril in patients with systemic hypertension: a randomized, double-blind, placebo-controlled, parallel-group study. The Benazepril/Amlodipine Study Group. J Clin Pharmacol 35 (11): 1060–1066.PubMedGoogle Scholar
  18. 18.
    Morgan TO, Anderson A, Jones E (1997) Comparison and interaction of low dose felodipine and enalapril in the treatment of essential hypertension in elderly subjects. Am J Hypertens 5: 238–243.CrossRefGoogle Scholar
  19. 19.
    Epstein M, Bakris G (1996) Newer approaches to antihypertensive therapy: use of fixed-dose combination therapy. Arch Intern Med 156 (17): 1969–1978.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • L. Michael Prisant

There are no affiliations available

Personalised recommendations